Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects Of Pre-emptive Single Oral Dose Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section

NCT04622202 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT04622202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04622202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects Of Pre-emptive Single Oral Dose Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
Lead sponsor
Zagazig University
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 15, 2020
Completion date
March 1, 2021
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety state, sedation